X-tosis, Inc.
PrivateLast Round
Grant
Jun 23, 2026
Total Funding Raised
$2.74M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
X-tosis, Inc. is a biotechnology company that develops first-in-class mitochondrial therapeutics targeting VDAC1 oligomerization to treat neurodegenerative diseases such as Alzheimer's and Parkinson's.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Vertical SaaS
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
X-tosis, Inc. Comparables
Compare X-tosis, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Capacity Bio | 44% | |
| ScandiBio Therapeutics | 42% | |
| MitoSense, Inc. | 34% |
X-tosis, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 23, 2026 |
Key People
Founding team and executive leadership
X-tosis, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 23, 2026
Received $2.74M from The Michael J. Fox Foundation
Recent news
Latest coverage and updates
- receives_financingJun 23, 2026
X-tosis, Inc. received financing of $2.74M in Grant on Jun 23rd '26.
X-tosis, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about X-tosis, Inc.'s valuation, stock price, and market status.
Is X-tosis, Inc. a public or private company?
X-tosis, Inc. is a private company.
What is the current stock price of X-tosis, Inc.?
X-tosis, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is X-tosis, Inc. worth (valuation)?
Valuation information for X-tosis, Inc. is not publicly available.
Can I buy X-tosis, Inc. stock?
X-tosis, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was X-tosis, Inc.'s last funding round?
X-tosis, Inc.'s most recent funding round was Grant on June 23, 2026.
Who are the main investors in X-tosis, Inc.?
Key investors in X-tosis, Inc. include The Michael J. Fox Foundation for Parkinson's Research.
Will X-tosis, Inc. IPO soon?
No public IPO plans have been announced for X-tosis, Inc..
How can I track X-tosis, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor X-tosis, Inc.'s secondary market activity and sign up for updates.